Search
for
Sort by
Research 91–120 of 1000+
- Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population
- Cancer risk in patients with alopecia areata: a nationwide population‐based matched cohort study
- Increased risk of fractures in patients with polycystic ovary syndrome: a nationwide population-based retrospective cohort study
- Longitudinal Assessment of the Prevalence of Actinic Keratosis and Extensive Risk Factor Evaluation: An Update from the Rotterdam Study
- The risk of dermatological toxicities of combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma patients: a systematic review and meta-analysis
- Cancer risk by the subtype of alopecia
- The Risk of Venous Thromboembolism (VTE) in Men with Benign Prostatic Hyperplasia Treated with 5-Alpha Reductase Inhibitors (5ARIs).
- Cardiometabolic Risk Factors in Atorvastatin-Treated Women with Euthyroid Autoimmune Thyroiditis
- Differential risk for COVID-19 in the first wave of the disease (February-April 2020) among migrants from several areas of the world living in Alcorcón (Spain): A population-based cohort study
- Increased risk of alopecia areata in patients with autism spectrum disorders: A Korean nationwide population-based study
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study
- The Progressive Loss Risk Scale for Hair Restoration Surgery
- Cardiovascular risk factors and co-morbidities in patients with Alopecia Areata: A case-control study
- Comments on “ Early androgenetic alopecia as a possible indicator of diabetes mellitus and its link to cardiovascular risks: a cross-sectional study ”
- Depression risk of 5-alpha reductase inhibitors: impact of active-comparator versus non-drug user control groups on risk measurement
- Global sex disparities in lifetime risk of alopecia areata: a systematic analysis from the global burden of disease study, 1990 to 2021
- Prevalence of Metabolic Syndrome and Cardiovascular Risk Factors in Early Onset Male Androgenetic Alopecia - A Cross Sectional Study in a Tertiary Care Hospital
- 0248 Risk of infections in patients with hidradenitis suppurativa treated with TNF-α inhibitors vs. IL-17 inhibitors: A large-scale cohort study
- Cardiovascular Risks in Women with Polycystic Ovary Syndrome (PCOS): A Narrative Review
- Suicidality Risks Associated with Finasteride, a 5-Alpha Reductase Inhibitor: An Evaluation of Real-World Data from the FDA Adverse Event Reports
- Finasteride: risk of suicidality and depression
- Potential Risks of Minoxidil in Pheochromocytoma and Paraganglioma: A Commentary on Safety Concerns and Mechanisms
- “Low‐risk” myelodysplastic neoplasm (MDS): Time for a name change?
- Abstract 850: Androgenic alopecia and risks of overall and aggressive prostate cancer: An updated meta-analysis
- Increased Risk of Local Recurrence in Cutaneous Squamous Cell Carcinoma Arising in Sun-Exposed Skin: A Retrospective Cohort Study
- Cardiovascular risk in patients with scarring and nonscarring alopecias: Assessing the current state of evidence
- Cancer risk in polycystic ovary syndrome patients: Common treatments and future perspectives
- Oral contraceptives and risk of breast cancer in women aged 20–54 years
- Circulating and/or cutaneous irisin resistance: A novel link among androgenetic alopecia, comorbid metabolic syndrome and cardiovascular risks